Barry Callebaut guides FY26-27 volume growth of 1% to 3%, recurring EBIT growth of 3% to 5% in constant currency, and PBT growth of around 30%. It expects free cash flow of 200 to 300 million.
BYCBF · Barry Callebaut AG
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Confectioners — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BYCBF
this stock
Barry Callebaut AG
|
$8.56B | -5.7% | — | — | 0.5% |
|
MDLZ
Mondelez International, Inc.
|
$85.49B | +25.5% | +5.8% | 21.2 | 2.3% |
|
HSY
Hershey Co
|
$35.02B | -4.2% | +2.0% | — | 4.8% |
|
CHLSY
Chocoladefabriken Lindt & Spruengli AG
|
$23.30B | -29.2% | — | — | 0.0% |
|
TR
Tootsie Roll Industries Inc
|
$2.86B | — | +1.3% | — | 3.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BYCBF | +25.6% | +7.7% | -9.6% | +12.4% | -5.7% |
| SPY | +0.1% | -3.3% | +2.6% | -0.4% | +10.4% |
| vs SPY | +25.6% | +10.9% | -12.2% | +12.8% | -16.1% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.